The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
it's a subcutaneous injection but after the first Baseline in three months it's given every six months so it's designed to be given in a clinic setting as opposed to monoclonal antibodies which people give it home and the frequency of every six months may be attractive for adherence because you give it in the clinic only one more time a year than a flu shot
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.